Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 26;340(6131):471-5.
doi: 10.1126/science.1231031.

PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria

Affiliations

PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria

Yun Chen et al. Science. .

Abstract

Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two Parkinson's disease factors, the mitochondrial kinase PINK1 (PTEN-induced putative kinase protein 1; PTEN is phosphatase and tensin homolog) and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and the identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes and in Parkin-deficient Drosophila heart tubes, causing dilated cardiomyopathy. Thus, Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Interaction of Mfn2 with Parkin in a PINK1-dependent manner and its requirement for Parkin translocation to depolarized mitochondria
(A and B) Fibroblasts were transfected with Flag-Mfn1 (A) or Mfn2 (B), PINK1, and/or HA-Parkin, immunoprecipitated with anti-Flag, and immunoblotted (IB). Right panels show IB of input homogenates. (C) Subcellular Parkin redistribution (green) induced by mitochondrial depolarization with FCCP in wild-type, Mfn1-deficient, and Mfn2-deficient mouse cardiomyocytes.
Fig. 2
Fig. 2. Defective ubiquitination and mitophagy in Mfn2-deficient mouse hearts
(A) Mfn2 ubiquitination in PINK1/Parkin-containing HEK cell immune complexes (left). Input proteins are on right. (B) Protein ubiquitination stimulated by FCCP in Mfn2/Parkin immune complexes from mouse heart. (C) Mitochondrial ubiquitination (green) induced by FCCP in wild-type, Mfn1-, and Mfn2-deficient mouse cardiomyocytes. Cell borders are outlined in white. (D) Parallel studies of mitophagy-adaptor protein p62/SQSTM1 (green).
Fig. 3
Fig. 3. PINK1 Phosphorylation of Mfn2 T111 and S442 dictates Parkin binding
(A) Mfn2 electrophoretic mobility shifts (arrowheads) induced by PINK1 in SDS-PAGE (top) and Phos-Tag (bottom) gels. Exploded view of lanes 4 and 5 is shown to the right. (B) PINK1-mediated Mfn2 phosphorylation (arrowheads) by anti-phosphoserine immunoblot (IB). (C) (left) Mfn2-Parkin co-immunoprecipitation study with functional and kinase-defective (KD) PINK1; (right) Mfn2 Phos-Tag phosphorylation study with functional and KD PINK1. (D) Effects of Mfn2 T111A and S442A mutations on PINK-stimulated Mfn2-Parkin binding. (E) Abrogation of PINK1-stimulated Mfn2-Parkin binding by Mfn2 T111A/S442A mutation and induction of PINK1-independent Mfn2-Parkin binding by Mfn2 T111E/S442E mutation.
Fig. 4
Fig. 4. Progressive cardiomyopathy of Mfn2-deficient mouse hearts and Parkin-deficient Drosophila heart tubes
(A) Transmission electron microscopic examination of mouse cardiomyocyte mitochondria (5,000x). (B) Whole cell O2 consumption studies of cadiomyocytes isolated from wild-type (black) or Mfn2-deficient (red) mouse hearts. (C) M-mode echocardiograms of mouse hearts. (D) Confocal imaging of Drosophila cardiomyocyte mitochondria. (E) O2 consumption studies of heart tubes isolated from wild-type (black) or Parkin-deficient (red) Drosophila. (F) Optical coherence tomography of Drosophila heart tubes. (G) Mitochondrial ubiquitination (green) induced by FCCP in wild-type and Parkin-deficient Drosophila cardiomyocytes.

Comment in

Similar articles

Cited by

References

    1. Schapira AH. Mitochondrial disease. Lancet. 2006;368:70–82. - PubMed
    1. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12:9–14. - PMC - PubMed
    1. Narendra DP, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:e1000298. - PMC - PubMed
    1. Gegg ME, et al. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet. 2010;19:4861–4870. - PMC - PubMed
    1. Rakovic A, et al. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PloS One. 2011;6:e16746. - PMC - PubMed

Publication types

MeSH terms